Victorian evolution of inherited retinal diseases natural history registry (VENTURE study): Rationale, methodology and initial participant characteristics
Open Access
- 12 June 2022
- journal article
- research article
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 50 (7), 768-780
- https://doi.org/10.1111/ceo.14110
Abstract
Background Emerging treatments are being developed for inherited retinal diseases, requiring a clear understanding of natural progression and a database of potential participants for clinical trials. This article describes the rationale, study design and methodology of the Victorian Evolution of inherited retinal diseases NaTUral history REgistry (VENTURE), including data from the first 150 participants enrolled. Methods VENTURE collects retrospective and prospective data from people with inherited retinal diseases. Following registration, participants are asked to attend a baseline examination using a standardised protocol to confirm their inherited retinal disease diagnosis. Examination procedures include (i) retinal function, using visual acuity and perimetry; (ii) retinal structure, using multimodal imaging and (iii) patient-reported outcomes. Participants' molecular diagnoses are obtained from their clinical records or through targeted-panel genetic testing by an independent laboratory. Phenotype and genotype data are used to enrol participants into disease-specific longitudinal cohort sub-studies. Results From 7 July 2020 to 30 December 2021, VENTURE enrolled 150 registrants (138 families) and most (63%) have a rod-cone dystrophy phenotype. From 93 participants who have received a probable molecular diagnosis, the most common affected genes are RPGR (13% of all registrants), USH2A (10%), CYP4V2 (7%), ABCA4 (5%), and CHM (5%). Most participants have early to moderate vision impairment, with over half (55%) having visual acuities of better than 6/60 (20/200) at registration. Conclusions The VENTURE study will complement existing patient registries and help drive inherited retinal disease research in Australia, facilitating access to research opportunities for individuals with inherited retinal diseases.Keywords
Funding Information
- Cass Foundation
- Novartis Pharmaceuticals Corporation
- Retina Australia
- University of Melbourne (Driving Research Momentum Fellowship, Melbourne Medical School Strategic Grant)
This publication has 41 references indexed in Scilit:
- Establishment and evolution of the Australian Inherited Retinal Disease Register and DNA BankClinical & Experimental Ophthalmology, 2012
- The Berkeley Rudimentary Vision TestOptometry and Vision Science, 2012
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2008
- Depression and the vision-related quality of life in patients with retinitis pigmentosaBritish Journal of Ophthalmology, 2008
- The Impact of Vision Impairment Questionnaire: An Assessment of Its Domain Structure Using Confirmatory Factor Analysis and Rasch AnalysisInvestigative Ophthalmology & Visual Science, 2007
- The Impact of Vision Impairment Questionnaire: An Evaluation of Its Measurement Properties using Rasch AnalysisInvestigative Ophthalmology & Visual Science, 2006
- Vision and Quality of Life: The Development of a Utility MeasureInvestigative Ophthalmology & Visual Science, 2005
- The multifocal electroretinogram (mfERG) and cone isolating stimuli: Variation in L- and M-cone driven signals across the retinaJournal of Vision, 2002
- The validity of the Hospital Anxiety and Depression ScaleJournal of Psychosomatic Research, 2002
- Lens Opacities Classification System II (LOCS II)American Journal of Ophthalmology, 1989